BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11042924)

  • 21. [Drug allergy in children].
    Patriarca G; Venuti A; Schiavino D; Romano A; Di Rienzo V
    Recenti Prog Med; 1982 Mar; 72(3):371-8. PubMed ID: 6980435
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
    Nizankowska-Mogilnicka E; Bochenek G; Mastalerz L; Swierczyńska M; Picado C; Scadding G; Kowalski ML; Setkowicz M; Ring J; Brockow K; Bachert C; Wöhrl S; Dahlén B; Szczeklik A
    Allergy; 2007 Oct; 62(10):1111-8. PubMed ID: 17521312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced bronchospasm.
    Prescrire Int; 2003 Apr; 12(64):64. PubMed ID: 12674128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No proof of cross-reactivity between celecoxib and antibiotic sulfonamides.
    Smith WB; Mullins RJ
    Intern Med J; 2007 May; 37(5):347-8. PubMed ID: 17504291
    [No Abstract]   [Full Text] [Related]  

  • 27. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allergic reactions to nonsteroidal anti-inflammatory drugs].
    Leimgruber A
    Rev Med Suisse; 2008 Jan; 4(140):100-3. PubMed ID: 18309871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
    Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
    J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.
    Mastalerz L; Sanak M; Gawlewicz A; Gielicz A; Faber J; Szczeklik A
    J Allergy Clin Immunol; 2006 Oct; 118(4):957-8. PubMed ID: 17030252
    [No Abstract]   [Full Text] [Related]  

  • 33. [Neither skin tests nor challenge tests are sufficient to provide formal diagnosis of drug allergy or sensitisation. A discussion of the article "Two medicines of similar imputability in dermal adverse drug reactions (two cases): the limitations of epicutaneous testing?" by P. Dellestable et al].
    Augey F; Guneraa-Saad N; Bérard F; Nicolas JF
    Ann Dermatol Venereol; 2008 Dec; 135(12):867-8. PubMed ID: 19084703
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 35. The safety of celecoxib in patients with aspirin-sensitive asthma.
    Woessner KM; Simon RA; Stevenson DD
    Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection.
    Dewachter P; Mouton-Faivre C
    Allergy; 2005 May; 60(5):705-6. PubMed ID: 15813822
    [No Abstract]   [Full Text] [Related]  

  • 37. [Warnings issued by the Ministry of Health on the safety of antibiotics, anti-inflammatory analgesics and lidocaine].
    Tamura T
    Nihon Shika Ishikai Zasshi; 1984; 36(10):1193-200. PubMed ID: 6332159
    [No Abstract]   [Full Text] [Related]  

  • 38. Selection of patients for aspirin desensitization treatment.
    Stevenson DD; Simon RA
    J Allergy Clin Immunol; 2006 Oct; 118(4):801-4. PubMed ID: 17030229
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid oral aspirin desensitization for patients with aspirin allergy requiring dual antiplatelet therapy.
    Hobbs L; Lyle B
    Conn Med; 2008 Feb; 72(2):87-9. PubMed ID: 18306836
    [No Abstract]   [Full Text] [Related]  

  • 40. What do we know about the genetics of aspirin intolerance?
    Palikhe NS; Kim SH; Park HS
    J Clin Pharm Ther; 2008 Oct; 33(5):465-72. PubMed ID: 18834360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.